eCential Robotics Appoints Clément Vidal as New Chief Executive Officer
GIÈRES (GRENOBLE), France and NASHVILLE, Tenn., July 18, 2024 /PRNewswire/ -- eCential Robotics is pleased to announce the appointment of...
Healthcare
Certify Releases Blueprint Report for Provider Credentialing Automation
Findings show that automated data acquisition and system integration enhance provider data accuracy, reduce administrative costs, and enhance patient care...
Axxess 2025 AGILE Conference to be held May 5-7 in Dallas
DALLAS, July 18, 2024 /PRNewswire/ -- Axxess, the leading global technology innovator for healthcare at home, today announced the 2025...
Eyenuk Appoints Bryan Haardt as Chief Executive Officer
Haardt brings decades of digital healthcare experience to build on Eyenuk's global mission of using AI to detect and prevent...
Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer’s biosimilar to Humira®
First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18,...
Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning
Webcast on Tuesday, July 23rd at 8:30 AM Eastern will include updates on Jaguar's cancer supportive care portfolio, including participation...
Therma Bright Engages Independent Trading Group as Market Maker
Toronto, Ontario--(Newsfile Corp. - July 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the...
ADIA Nutrition Inc. Announces Restructuring, Unveiling Two Dynamic Divisions
Winter Park, Florida--(Newsfile Corp. - July 18, 2024) - ADIA Nutrition Inc., (OTC Pink: ADIA) proudly announces a strategic restructuring...
InnovaCare Health Welcomes Kat Alvarez as Chief Strategy Officer
Alvarez will focus on strategic development in the healthcare ecosystem to drive access to high-quality healthcare as the risk-bearing organization...
Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology...
Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery
‘Breaking Barriers’ Coalition Formed to Address Opioid Use Disorder in the USA Nexalin CEO Mark White Participates in Inaugural Meeting...
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults
VOQUEZNA is now approved and available to treat the largest category of Gastroesophageal Reflux Disease (GERD)VOQUEZNA met its primary endpoint...
Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy
BALTIMORE, Md. and BASKING RIDGE, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company,...
Inovalon’s Converged Quality Achieves 24th Consecutive NCQA HEDIS® Certification
The Company’s Solutions are Trusted by the Health Plans Representing 80% of all U.S. Covered Lives to Deliver HEDIS Results...
OPKO Health Announces $100 Million Share Repurchase Program
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has...
HealthyMD and IMG Health Clinic Unite to Advance Health Equity and Access to Care for 50M+ Underserved People Across the U.S.
Groundbreaking hybrid care model elevates standard of care for sexual healthcare of underserved populations, improves quality of life, and strengthens...
CareTalk Health Revolutionizes Healthcare by Launching First Clinical Process Outsourcing Company Nationwide
With the ability to bill Medicare in all 50 states, CareTalk Health offers licensed physicians and clinicians in every state,...
New data for Roche’s Susvimo demonstrates sustained efficacy in two serious diabetic eye conditions
Two-year Phase III data presented at ASRS 2024 show Susvimo’s potential as an alternative to eye injections to treat diabetic...
Aveanna Announces Second Quarter 2024 Earnings Release Date and Conference Call
ATLANTA, July 18, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will...
Teleflex Announces Second Quarter 2024 Earnings Conference Call Information
WAYNE, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second...